Cholesterol drug may help children with malaria

12/28/2012 | Voice of America

An international team of researchers found that adding the cholesterol drug lovastatin to malaria treatment chloroquine could prevent the late cognitive problems associated with cerebral malaria, according to a mouse model study published in the journal PLoS Pathogens. Lead researcher Dr. Guy Zimmerman of the University of Utah says lovastatin should be added to treatments for malaria.

View Full Article in:

Voice of America

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA